A new research study by Transparency Market Research (TMR) provides an all-inclusive evaluation of the global market for vascular stents. The research report, titled “Vascular Stents Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” assesses the prominent trends, growth boosters, obstructions, market potentials, opportunities, and the challenges to find out the future prospects and performance of this market.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8191
As per the research report, the rising prevalence of cardiovascular diseases among people across the world is the main factor that has been boosting the growth of the global market for vascular stents and is anticipated to continue doing so over the next few years, reports the market study.
The global market for vascular stents can broadly be assessed on the basis of the material and the regional presence of the market. Based on the material, the market can be classified into metal stents, standard polymeric stents, and biodegradable polymeric stents. Based on the geography, the market can be divided into Europe, the Middle East and Africa, North America, Asia Pacific, and Latin America.
North America has been dominating the global market on account of the increasing number of people suffering from cardiovascular diseases (CVDs) and the absence of physical activities among people’s daily routine in this region. Unhealthy diet is also a major factor behind the prevalence of CVDs among North American citizens, which consequently, is supporting the growth of the North America market for vascular stents market, currently, and will remain doing so over the forthcoming years, notes the market study.
The competitive analysis of the global market for vascular stents has also been offered in this research report. It conducts a thorough study of the prominent vendors of vascular stents solutions across the world, such as Cook Medical, InnoCore Technologies BV, Goodman Co. Ltd., Abbott Laboratories, Biosensors International Ltd., Cordis Corp., MIV Therapeutics Inc., Reva Medical Inc., MicroPort Scientific Corp., Boston Scientific Corp., Translumina GmbH, Stentys SA, Allvivo Vascular Inc., Medtronic Inc., X-Cell Medical Inc., SurModics Inc., and Xtent Inc. These participants are projected to focus on strategic collaborations to strengthen their positions in the global market in the years to come, states the research study.